Posted: 4 May 2023 Universal Biosensors, is delighted to announce it has today launched its PETRACKR blood glucose monitoring product for dogs and cats with diabetes globally. To coincide with the launch, UBI announces it has signed three…
Posted: 4 May 2023 Telix today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalTrials.gov Identifier: NCT03849118). The results were featured in a late-breaking oral…
Posted: 4 May 2023 Telix announces first patients have been imaged in Canada with its commercially available prostate cancer imaging agent, Illuccix® [kit for the preparation of gallium (68Ga) PSMA-11 for intravenous injection]. With Illuccix now available nationwide…
Posted: 4 May 2023 Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received regulatory approval from the Paul-Ehrlich-Institut (“PEI”), German Federal Institute for Vaccines and Biomedicines, to…
Posted: 4 May 2023 Respiratory imaging technology company 4DMedical Limited announces the successful completion of the first commercial XV LVAS scan within the VA, conducted at Harry S. Truman Memorial Veterans Hospital in Colombia, Missouri. First commercial scan…
Posted: 1 May 2023 Atmo Biosciences, a company commercializing the world’s first ingestible gas-sensing capsule that provides insights into gut health and microbiome function, today announced the appointment of renowned gastroenterologist Professor Eamonn Quigley as Chair of its…
Posted: 1 May 2023 Cartherics Pty Ltd, a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it has granted Shunxi Holding Group Co Ltd (“Shunxi”) a licence to develop, manufacture and commercialise…
Posted: 1 May 2023 Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received regulatory approval from the Paul-Ehrlich-Institut (“PEI”), German Federal Institute for Vaccines and Biomedicines, to…
Posted: 27 April 2023 Closes: 16 June 2023 Nominations are now open for the 2023 GSK Award for Research Excellence! The GSK Award for Research Excellence (ARE) is one of the most prestigious and longstanding awards available to…
Posted: 27 April 2023 Cytiva and the University of Adelaide are collaborating with BioCina, an Australian-based multi-product biologics contract development and manufacturing organization (CDMO), to expand its facility in Adelaide to manufacture mRNA-based vaccines and therapies. Fellow Danaher…
Posted: 27 April 2023 Melbourne continues to lead the way as the preferred destination for medical conferences, with the Melbourne Convention Bureau (MCB) securing a massive 48 events to take place within the next five years. Firmly placing…
Posted: 27 April 2023 Monash University has announced the establishment of two new sub-faculties within the Faculty of Medicine, Nursing and Health Sciences (MNHS), the Sub-Faculty of Health Sciences and the Sub-Faculty of Clinical and Molecular Medicine. Professor…